Independent cost intelligence for Ozempic, Wegovy, Mounjaro, and Zepbound. Switch state and coverage below — then run the Affordability Audit™ for your personal score.
Drug Matrix™
Compare all 4 GLP-1s side-by-side
ozempic$969$25/mo
−97%
wegovy$1,349$25/mo
−98%
mounjaro$1,112$25/mo
−98%
zepbound$1,086$25/mo
−98%
Lowest in Texas: Ozempic (semaglutide) at $25/mo (card)
Live data
Top states by Affordability Score
| # | State | Score | Est./mo |
|---|---|---|---|
| 1 | AL | 98 | $25 |
| 2 | AK | 98 | $25 |
| 3 | AZ | 98 | $25 |
| 4 | AR | 98 | $25 |
| 5 | CA | 98 | $25 |
| 6 | CO | 98 | $25 |
| 7 | CT | 98 | $25 |
| 8 | DE | 98 | $25 |
Truth Checker™
That $25/mo ad — real or bait?
Toggle 8 hidden cost traps: prior auth gaps, supply fees, telehealth visits, savings card caps. See your true monthly before you sign up with a provider.
- ! Savings cards often cap at 12 months
- ! Medicare rarely covers weight-loss GLP-1
- ! Compounded ≠ FDA-approved brand drug
Knowledge base